ERBB2 and breast cancer: Contrast enhancement studies in experimental brain metastasis models of TNBC and HER2+ BC revealed a leaky BTB in more than 90% of brain metastatic lesions and a substantial heterogeneity between different metastatic lesions within brains in these patients.